Raymond James & Associates’s Core Laboratories CLB Stock Holding History

Raymond James & Associates’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,270	Closed	-$659K	–	3975
2022 Q2	$659K	Sell	33,270 -29,319	-47%	-$779K	﹤0.01%	2732
2022 Q1	$1.98M	Buy	+62,589	New	+$1.75M	﹤0.01%	2142
2021 Q3	–	Sell	-11,206	Closed	-$436K	–	4138
2021 Q2	$436K	Buy	11,206 +1,044	+10%	+$37.4K	﹤0.01%	3187
2021 Q1	$293K	Buy	+10,162	New	+$347K	﹤0.01%	3371
2020 Q3	–	Sell	-12,462	Closed	-$253K	–	3597
2020 Q2	$253K	Sell	12,462 -27,688	-69%	-$496K	﹤0.01%	3013
2020 Q1	$415K	Sell	40,150 -62,062	-61%	-$1.74M	﹤0.01%	2547
2019 Q4	$3.85M	Sell	102,212 -20,261	-17%	-$910K	﹤0.01%	1417
2019 Q3	$5.71M	Sell	122,473 -4,837	-4%	-$225K	0.01%	1144
2019 Q2	$6.66M	Buy	127,310 +4,884	+4%	+$286K	0.01%	1077
2019 Q1	$8.44M	Buy	122,426 +13,703	+13%	+$919K	0.01%	898
2018 Q4	$6.48M	Sell	108,723 -57,994	-35%	-$5M	0.01%	972
2018 Q3	$19.3M	Buy	166,717 +19,971	+14%	+$2.25M	0.03%	538
2018 Q2	$18.5M	Buy	146,746 +15,915	+12%	+$1.94M	0.03%	533
2018 Q1	$14.2M	Buy	130,831 +27,759	+27%	+$3.07M	0.03%	604
2017 Q4	$11.3M	Sell	103,072 -469	-0.5%	-$46.8K	0.02%	710
2017 Q3	$10.2M	Sell	103,541 -1,613	-2%	-$156K	0.02%	719
2017 Q2	$10.6M	Buy	105,154 +19,423	+23%	+$2.09M	0.02%	673
2017 Q1	$9.9M	Buy	85,731 +4,549	+6%	+$529K	0.02%	677
2016 Q4	$9.74M	Sell	81,182 -13,527	-14%	-$1.5M	0.02%	642
2016 Q3	$10.6M	Buy	94,709 +21,637	+30%	+$2.49M	0.03%	573
2016 Q2	$9.05M	Buy	73,072 +2,766	+4%	+$334K	0.03%	575
2016 Q1	$7.9M	Sell	70,306 -12,170	-15%	-$1.26M	0.03%	605
2015 Q4	$8.97M	Buy	82,476 +63,369	+332%	+$7.25M	0.03%	556
2015 Q3	$1.91M	Buy	19,107 +1,929	+11%	+$210K	0.01%	1245
2015 Q2	$1.96M	Buy	17,178 +3,805	+28%	+$461K	0.01%	1330
2015 Q1	$1.4M	Buy	+13,373	New	+$1.42M	0.01%	1464